Seneca Biopharma, Inc. Announces Adjournment of Annual Meeting of Stockholders
Seneca Biopharma, Inc., a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, announced that its 2020 Annual Meeting of Stockholders that convened on August 7, 2020 has been adjourned until September 4, 2020 at 2:00 p.m. Eastern Time in order to solicit additional proxies for Proposal 3, Proposal 4, and Proposal 7 as described above. … Continue reading Seneca Biopharma, Inc. Announces Adjournment of Annual Meeting of Stockholders Continue Reading
REX, the real estate technology company connecting residential real estate buyers and sellers and the lowest transaction costs in the industry, has announced national sales figures in July were the highest in the company’s history. Nationwide REX experienced a 123 percent increase in homes going into escrow from April to July – despite the impacts … 
Alphamin Resources Corp. is pleased to report its financial results for the quarter ended June 2020. The Company has filed on SEDAR at www.sedar.com today its interim financial statements and related management’s discussion and analysis for the quarter. FINANCIAL AND OPERATIONAL HIGHLIGHTS Tin production up 29% to 2,739 tons versus previous quarter AISC per ton of tin sold down 13% to US$10,849 versus previous … 
AnyCurb will begin offering the ecobee SmartThermostat with voice control for free to homebuyers with the purchase of a home with an AnyCurb real estate agent. The Data-Driven Real Estate Brokerage, which seeks to increase housing supply by making off-market homes attainable for homebuyers, announced the incentive program earlier this week. The goals of this program are to promote sustainability, … 
Osisko Metals Incorporated is pleased to announce that it has closed its previously-announced non-brokered private placement, pursuant to which the Corporation sold an aggregate of 7.5 million units of the Company (each, a “Unit“) at a price of $0.40 per Unit for aggregate gross proceeds of $3 million (the “Offering“). Each Unit consists of one common … 
Plus Therapeutics, Inc. announced financial and business results for its Second Quarter Fiscal Year 2020 ended June 30, 2020. Q2 2020 net loss was $1.8 million, or $0.45 per share, including payments to NanoTx LLC of $0.78 million. Net cash used in operating activities for the six months ended June 30, 2020 was approximately $2.9 million. …